Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors mediate marked visual restoration
NISHIGUCHI, K. M.; Fujita, K.; Miya, F.; Katayama, S.; Nakazawa, T.
Show abstract
The most versatile treatment for inherited disorders is to precisely replace a mutated sequence with its wildtype counterpart, thereby "normalizing" the genome. We developed a single AAV platform that allows this in retinal neurons with combined CRISPR-Cas9 and micro-homology-mediated end-joining. In blind mice, the platform rescued ~10% of the retinal neurons, resulting in an incredible ~10,000-fold improvement in light sensitivity, equivalent to the restoration mediated by conventional gene augmentation therapy.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Specialization of the photoreceptor transcriptome by Srrm3-dependent microexons is required for outer segment maintenance and vision 93%
- Comprehensive preclinical evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of C9ORF72 disease 92%
- Introduced chemokine gradients guide transplanted and regenerated retinal neurons toward their natural position in the retina 92%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.